Candoxatrilat
Alternative Names: UK 73967Latest Information Update: 23 Jul 2002
At a glance
- Originator Pfizer
- Class Heart failure therapies; Small molecules
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Heart failure; Renal failure
Most Recent Events
- 23 Jun 2000 Pfizer has merged with Warner-Lambert
- 05 Aug 1999 Phase-I clinical trials for Renal failure in United Kingdom (IV)
- 29 Dec 1998 Investigation in Renal failure in United Kingdom (IV)